Adults with type 2 diabetes treated with Novo Nordisk's Victoza ® , in combination with metformin, experienced similar improvements in blood glucose control while fasting during the four weeks of Ramadan compared with sulfonylurea (SU) plus ... Nordic Life Science, 3 weeks ago
New Study With Victoza(R) (Liraglutide) Showed Improvements in Blood Glucose Control in Adults With Type 2 Diabetes Who Fasted During Ramadan - Bloomberg, 3 weeks ago
New Study With Victoza® (Liraglutide [rDNA Origin] Injection) Showed Improvements in Blood Glucose Control in Adults With Type 2 Diabetes Who Fasted During Ramadan - MoneyShow.com, 3 weeks ago
ELI LILLY : Study: Once-Weekly Trulicity dulaglutide Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® liraglutide in Japanese Patients...
Study: Once-Weekly Trulicity dulaglutide Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® liraglutide in Japanese Patients after 52 weeks By a News Reporter-Staff News Editor at Diabetes Week -- Results from a new study of ...4 Traders, 2 weeks ago Study: Once-Weekly Trulicity (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks Pharma Voice, 3 weeks ago Study: Once-Weekly Trulicity(TM) (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks Individual.com, 3 weeks ago Study: Once-Weekly Trulicity??? (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza?? (liraglutide) in Japanese Patients after 52 weeks Review Seeker, 3 weeks ago
Novo Nordisk A/S NVO announced new data from a couple of studies on its approved products, Xultophy and Victoza, during the weekend. Firstly, Novo Nordisk reported that the company's type II diabetes drug Xultophy led to a statistically ...Yahoo! Finance, 3 weeks ago
More from: Yahoo! News, Nasdaq...and 1 other sources
COPENHAGEN, May 18 (Reuters) - Novo Nordisk is looking into recent clinical trial data that show its diabetes drug Victoza has potential as a treatment for fatty liver disease, a hot area for pharmaceutical development.Research from Britain's ...London South East, 1 month ago Novo Nordisk weighs diabetes drug's use in fatty liver disease Reuters India, 1 month ago REFILE-Novo Nordisk weighs diabetes drug's use in fatty liver disease London South East, 1 month ago
If you use insulin pens or take other injected diabetes medications (such as Symlin, Victoza, or Byetta), don't share your medication pen with anyone else—even if youve attached a new needle. Blood can get stuck inside the pen from previous use ...Diabetes Forecast, 2 days ago
Danish insulin giant Novo Nordisk has presented results at the American Diabetes Association meeting… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , take ...Pharma Letter, 3 weeks ago Expect Novo Nordisk To Commit To Their Late-Stage Diabetes Pill Development Soon Seeking Alpha, 1 week ago Novo Nordisk launches diabetes combination Pharmafile, 3 weeks ago Novo Nordisk And Its Promising Diabetes Drugs Seeking Alpha, 1 month ago
You attempted to read ViewPoints , exclusive content for FirstWord Pharma PLUS members. You currently are not registered for any FirstWord Pharma services. To gain instant access to ViewPoints plus additional enhanced content and features, please ...FirstWord Pharma, 3 weeks ago
following a full submission liraglutide (Victoza®) is accepted for use within NHS Scotland. Indication under review : For the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with basal insulin ...FirstWord Pharma, 1 month ago Scottish Medicines Consortium approves seven drugs Pharmafile, 1 month ago Scotland yes for UC and blood cancer meds Pharma Field, 1 month ago SMC accepts seven new medicines for use in NHS Scotland European Pharmaceutical Review, 1 month ago
In March 2013 the US Food and Drug Administration (FDA) announced results of a study suggesting Victoza side effects could include an increased risk of Victoza pancreatitis. Victoza has already reportedly been linked in animal studies to an ...Lawyers & Settlements, 1 month ago
Action Points Note that this randomized trial of liraglutide found that it was superior to placebo in terms of weight loss at 56 weeks. Be aware that significantly more patients withdrew from the liraglutide group due to adverse events compared ...MedPage Today, 6 hours ago GI Events Do Not Explain Weight Loss With Saxenda (CME/CE) MedPage Today, 1 month ago
on your WebpageAdd Widget >Get your members hooked!